Distribution of types of event and of survival status of children with T-lymphoblastic lymphoma according to genetic subgroups
. | Total population studied, n (%) . | Subgroup . | . | . | . | All HOX11L2-negative, n (%)† . | |||
---|---|---|---|---|---|---|---|---|---|
. | . | HOX11L2-positive, n (%) . | HOX11-high, n (%) . | SIL-TAL, n (%) . | Other, n (%)* . | . | |||
Total, N (%) | 11 (100) | 1 (100) | 1 (100) | 2 (100) | 7 (100) | 11 (100) | |||
Type of event | |||||||||
No event (ie, in CCR) | 10 (90.9) | 1 (100) | 1 (100) | 1 (100) | 6 (85.7) | 10 (90.9) | |||
BM only | 1 (9.1) | 0 (0) | 0 (0) | 0 (0) | 1 (14.3) | 1 (9.1) | |||
Survival status | |||||||||
Alive | 10 (90.9) | 1 (100) | 1 (100) | 1 (100) | 6 (85.7) | 10 (90.9) | |||
Dead | 1 (9.1) | 0 (0) | 0 (0) | 0 (0) | 1 (14.3) | 1 (9.1) |
. | Total population studied, n (%) . | Subgroup . | . | . | . | All HOX11L2-negative, n (%)† . | |||
---|---|---|---|---|---|---|---|---|---|
. | . | HOX11L2-positive, n (%) . | HOX11-high, n (%) . | SIL-TAL, n (%) . | Other, n (%)* . | . | |||
Total, N (%) | 11 (100) | 1 (100) | 1 (100) | 2 (100) | 7 (100) | 11 (100) | |||
Type of event | |||||||||
No event (ie, in CCR) | 10 (90.9) | 1 (100) | 1 (100) | 1 (100) | 6 (85.7) | 10 (90.9) | |||
BM only | 1 (9.1) | 0 (0) | 0 (0) | 0 (0) | 1 (14.3) | 1 (9.1) | |||
Survival status | |||||||||
Alive | 10 (90.9) | 1 (100) | 1 (100) | 1 (100) | 6 (85.7) | 10 (90.9) | |||
Dead | 1 (9.1) | 0 (0) | 0 (0) | 0 (0) | 1 (14.3) | 1 (9.1) |